Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering.Report...
-
Hummingbird Bioscience today announced that the first patient has been dosed in a Phase I clinical trial of HMBD-501.
-
SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's...
-
Dublin, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply & Logistics Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The clinical...
-
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs
-
Annovis will begin Open-Label Extension study in Parkinson's disease patients
-
SYDNEY, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that due to the recent accelerated screening and enrolment in the XanaMIA phase 2b/3 Alzheimer’s disease (AD)...
-
Annovis will host corporate update webinar on January 28, 2026
-
Beacon Biosignals partners with Harmony Biosciences to quantitatively measure excessive daytime sleepiness in phase 3 clinical trial.